Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 4.98M | $136.0M | 25.07% | -- | 2026-06-30 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 1.60M | $44.0M | 8.08% | -- | 2026-06-30 |
| Paradigm Biocapital Advisors LP | 1.55M | $42.0M | 7.83% | +888.5K | 2026-06-30 |
| Commodore Capital LP | 1.42M | $38.0M | 7.13% | +415.0K | 2026-06-30 |
| RA CAPITAL MANAGEMENT, L.P. | 1.02M | $28.0M | 5.14% | -- | 2026-06-30 |
| Jupiter Topco LLC | 849.3K | $23.0M | 4.28% | -- | 2026-06-30 |
| BlackRock, Inc. | 766.8K | $21.0M | 3.86% | +564.1K | 2026-06-30 |
| Parkman Healthcare Partners LLC | 721.2K | $19.0M | 3.63% | +310.0K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 558.9K | $15.0M | 2.82% | +68.5K | 2026-06-30 |
| Point72 Asset Management, L.P. | 460.6K | $12.0M | 2.32% | +116.5K | 2026-06-30 |
